Moneycontrol PRO
Black Friday Sale
Black Friday Sale
HomeNewsIndiaDelhi to reduce COVID-19 testing price to Rs 2,000-2,500: Report

Delhi to reduce COVID-19 testing price to Rs 2,000-2,500: Report

The move follows an advisory by Indian Council of Medical Research (ICMR) director-general Balram Bhargava

June 17, 2020 / 12:27 IST
Representative Image (Image: BMC)

The Delhi government is looking to slash coronavirus test rates by half of the current Rs 4,500. The state is in talks with private hospitals and diagnostic centres to discuss the same and tests could soon cost between Rs 2,000-2,500, sources told The Economic Times.

Moneycontrol could not independently verify the report.

Prices of testing kits reduce due to an increased number of local options. As the Indian Council of Medical Research (ICMR) said that price caps for RT-PCR testing would be removed, many states have already cut or are considering reducing prices for the process.

“This price was fixed at a time when testing kits were in short supply and had to be imported. With so many vendors now approved and the kits being indigenously produced, the price can be brought down,” a source in Delhi health services told ET.

Follow our LIVE Updates on the coronavirus pandemic here

Private testing centres are however not all on board, and said a price drop would “compromise quality.” They pointed out that testing costs for them includes more than just the kit.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

“For every test, the phlebotomist has to wear a new personal protective equipment (PPE). There is an additional cost of transportation and a particular medium in which the sample needs to be maintained. We are already conducting these tests on a no-profit basis,” the owner of a South Delhi lab told the paper.

Delhi would be following Maharashtra and Karnataka, which made similar moves and cut the test cost to Rs 3,000.

It also comes after Dr Balram Bhargava, director general, ICMR, and secretary, department of health research, Ministry of Health and Family Welfare asked state chief secretaries to “fix agreeable prices” for RT-PCR testing for COVID-19.

In a letter to states, ICMR said the reduced charges are justified as majority of testing material is now being made indigenously, Mint reported.

“All efforts have been made to facilitate local companies … Indigenous diagnostic kits are also being approved on a fast track basis for RT-PCR testing … testing supplies are also stabilised … Prices are becoming competitive and are undergoing reduction because of varied options," Dr Bhargava said in the letter written to chief secretaries of all states two weeks ago.

“The earlier upper ceiling of Rs 4,500 may not be applicable now. Therefore, all state governments and UT administrations are advised to negotiate with private labs and fix up mutually agreeable prices for samples being sent by the government and also for private individuals desirous of testing by these labs," Bhargava added.

Notably, testing at government hospitals has been free, while the Rs 4,500 cap was for private facilities. In case a private facility undertook tests for the government Rs 3,500 was reimbursed.

Sources added that Union Health Minister Harsh Vardhan has also “informally asked” private players to downward adjust prices.

Follow our full COVID-19 coverage here
Moneycontrol News
first published: Jun 17, 2020 12:27 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347